This online course describes an approach to the validation and compliance of computerized systems used in the manufacture of pharmaceuticals, biologicals, and medical devices that are required to meet FDA’s regulations. It identifies ways to organize policies and procedures, and plans FDA expects a manufacturing company to establish. This course draws on current industry good practice. Though it also draws on FDA medical device guidance, this course is not intended to describe an approach to developing software that subsequently becomes part of a medical device. This is the second course in a series of four courses. Before taking this course, you should have successfully completed Requirements for Computerized Systems Validation and Compliance.
Your company needs to have a specific approach to the validation and compliance of computerized systems. This course identifies ways to organize policies and procedures, and plans FDA would expect a regulated firm to establish to meet requirements. It further outlines an acceptable approach to defining an adequate validation strategy, discusses the documentation of the associated validation activities, and identifies what operation, maintenance, and control procedures the regulated healthcare customer or organization contracting a supplier to provide a product. The term is not intended to apply only to individuals who use the computerized system. Later courses in the series will address the inspection of computerized systems.
After more than four years of rework, the Good Automated Manufacturing Practices (GAMP) 4 Guide was reissued as GAMP 5 in March 2008. The GAMP Guide has been significantly updated to align with the concepts and terminology of recent regulatory and industry developments. GAMP 5 concepts, which focus on risk, will also be addressed in this course. This course addresses the following:
Take Back to Your Job:
After completing this course, you will be able to:
Attendance Suggested For: